Roquefort Investments PLC Cash Flow Conversion Efficiency

Latest as of June 2025: -0.069x

Roquefort Investments PLC cash flow conversion efficiency. Based on the latest financial reports, Roquefort Investments PLC (ROQ) has a cash flow conversion efficiency ratio of -0.069x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-329.55K ≈ $-40.10 USD) by net assets (GBX4.75 Million ≈ $578.29 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Roquefort Investments PLC (2021–2024)

Cash flow conversion efficiency of Roquefort Investments PLC from 2021 to 2024. This chart illustrates how Roquefort Investments PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Roquefort Investments PLC stock quote for real-time trading data and today's change.

Roquefort Investments PLC Cash Flow Conversion Ratio Explained

Roquefort Investments PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Roquefort Investments PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Roquefort Investments PLC ranked by their cash flow conversion efficiency. Also see market cap of Roquefort Investments PLC for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Symphony Environmental Technologies plc
LSE:SYM
0.236x
Checkit PLC
LSE:CKT
-0.132x
Adventure Box Technology AB
ST:ADVBOX
0.624x
Pennant International Group plc
LSE:PEN
0.136x
JDC Group AG
XETRA:JDC
0.053x
Ratu Prabu Energi Tbk
JK:ARTI
0.024x
Trustco Group Holdings
JSE:TTO
-0.004x
Northern Bear Plc
LSE:NTBR
0.123x

Annual Cash Flow Conversion Efficiency for Roquefort Investments PLC (2021–2024)

The table below shows the annual cash flow conversion efficiency of Roquefort Investments PLC from 2021 to 2024. Review Roquefort Investments PLC free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX4.89 Million
≈ $594.85
GBX-783.73K
≈ $-95.36
-0.160x +49.14%
2023-12-31 GBX5.50 Million
≈ $669.14
GBX-1.73 Million
≈ $-210.92
-0.315x -44.00%
2022-12-31 GBX7.21 Million
≈ $876.84
GBX-1.58 Million
≈ $-191.93
-0.219x +65.93%
2021-12-31 GBX4.08 Million
≈ $496.74
GBX-2.62 Million
≈ $-319.15
-0.642x --

About Roquefort Investments PLC

LSE:ROQ UK Biotechnology
Market Cap
$184.27K
GBX1.51 Billion GBX
Market Cap Rank
#31373 Global
#1028 in UK
Share Price
GBX9.25
Change (1 day)
+873.68%
52-Week Range
GBX0.95 - GBX9.25
All Time High
GBX12.50
About

Roquefort Therapeutics plc, a material biotech company, engages in the development of medicines for the treatment of cancer. Its product portfolio consists of five novel patent-protected pre-clinical anti-cancer medicines, which include Midkine antibodies with significance in vivo efficacy and toxicology studies, as well as orphan drug indication; Midkine RNA oligonucleotide therapeutics with nov… Read more